- Home
- APLT vs ADV Comparison
APLT vs ADV Comparison
Compare APLT & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ADV
- Stock Information
- Founded
- APLT 2016
- ADV 1987
- Country
- APLT United States
- ADV United States
- Employees
- APLT N/A
- ADV N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ADV Business Services
- Sector
- APLT Health Care
- ADV Consumer Discretionary
- Exchange
- APLT Nasdaq
- ADV Nasdaq
- Market Cap
- APLT 63.6M
- ADV 586.7M
- IPO Year
- APLT 2019
- ADV N/A
- Fundamental
- Price
- APLT $0.43
- ADV $1.88
- Analyst Decision
- APLT Buy
- ADV Strong Buy
- Analyst Count
- APLT 6
- ADV 1
- Target Price
- APLT $6.10
- ADV $2.50
- AVG Volume (30 Days)
- APLT 771.9K
- ADV 591.8K
- Earning Date
- APLT 11-06-2025
- ADV 11-06-2025
- Dividend Yield
- APLT N/A
- ADV N/A
- EPS Growth
- APLT N/A
- ADV N/A
- EPS
- APLT N/A
- ADV N/A
- Revenue
- APLT $121,000.00
- ADV $3,527,054,000.00
- Revenue This Year
- APLT N/A
- ADV N/A
- Revenue Next Year
- APLT $5,931.24
- ADV N/A
- P/E Ratio
- APLT N/A
- ADV N/A
- Revenue Growth
- APLT N/A
- ADV N/A
- 52 Week Low
- APLT $0.30
- ADV $1.04
- 52 Week High
- APLT $10.62
- ADV $4.10
- Technical
- Relative Strength Index (RSI)
- APLT 44.60
- ADV 55.23
- Support Level
- APLT $0.40
- ADV $1.77
- Resistance Level
- APLT $0.45
- ADV $1.99
- Average True Range (ATR)
- APLT 0.03
- ADV 0.10
- MACD
- APLT -0.01
- ADV -0.01
- Stochastic Oscillator
- APLT 24.29
- ADV 52.05
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.